The current lawsuits involving opioid manufacture, promotion and distribution bring to mind other drug company issues addressed in an article in Time magazine by Katherine Eban.

Ninety percent of the prescriptions filled in the U.S. are generic drugs, 80% of their active ingredients come from outside the country, and most insurance companies insist on generic drugs for in-plan payment. Over the years, we have praised generic drug manufacturers for helping to control medical costs but they have a deep, dark secret: drug manufacturers vary their standards based on the country buying their produc...